Improved Accuracy of Detection of Nasopharyngeal Carcinoma by Combined Application of Circulating Epstein–Barr Virus DNA and Anti-Epstein–Barr Viral Capsid Antigen IgA Antibody | Zendy

Sing-Fai Leung | Zendy; John S. Tam | Zendy; Anthony T.�C. Chan | Zendy; Benny Zee | Zendy; Lisa Chan | Zendy; Dolly P. Huang | Zendy; Andrew van Hasselt | Zendy; Philip J. Johnson | Zendy; Y. M. Dennis Lo | Zendy

Open Access

Improved Accuracy of Detection of Nasopharyngeal Carcinoma by Combined Application of Circulating Epstein–Barr Virus DNA and Anti-Epstein–Barr Viral Capsid Antigen IgA Antibody

Author(s) -

Sing-Fai Leung,

John S. Tam,

Anthony T.�C. Chan,

Benny Zee,

Lisa Chan,

Dolly P. Huang,

Andrew van Hasselt,

Philip J. Johnson,

Y. M. Dennis Lo

Publication year - 2004

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2003.022426

Subject(s) - nasopharyngeal carcinoma , epstein–barr virus , virus , antibody , antigen , capsid , immunology , herpesviridae , titer , virology , dna , biology , medicine , viral disease , genetics , radiation therapy

Circulating Epstein-Barr viral (EBV) DNA and anti-EBV capsid antigen IgA (IgA VCA) represent two of the most sensitive peripheral blood markers of nasopharyngeal carcinoma (NPC), but direct comparative studies of these two markers are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research